Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 May;93(5):789-90.
doi: 10.3324/haematol.12253.

A Prospective Study of the Separate Predictive Capabilities of 18[F]-FDG-PET and Molecular Response in Patients With Relapsed Indolent non-Hodgkin's Lymphoma Following Treatment With iodine-131-rituximab Radio-Immunotherapy

Free article
Clinical Trial

A Prospective Study of the Separate Predictive Capabilities of 18[F]-FDG-PET and Molecular Response in Patients With Relapsed Indolent non-Hodgkin's Lymphoma Following Treatment With iodine-131-rituximab Radio-Immunotherapy

Mark J Bishton et al. Haematologica. .
Free article

Similar articles

See all similar articles

LinkOut - more resources

Feedback